Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
29/04/2024 12:57
April 29 (Reuters) - Mosaic Immunoengineering Inc
CPMV.PK :
* ONCOTELIC THERAPEUTICS, INC. TO SELL ITS NECROPTOSIS
CANCER
THERAPY ASSETS TO MOSAIC IMMUNOENGINEERING, INC.
Source text for Eikon: ID:nGNX8BSQkc
Further company coverage: CPMV.PK
(Reuters.Briefs@thomsonreuters.com)